Many nations around the world, including Japan, are making significant investments in regenerative medicine. This is largely due to its potential to cure people of spinal injuries and help with recovery from strokes, among other various anticipated benefits. However, it is growing increasingly difficult for patients to unambiguously distinguish regenerative medical therapies that are medically proven from those still undergoing scientific investigations.